Bristlecone Advisors’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bristlecone Advisors’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-48	Closed	-$52K	–	290
2017 Q2	$52K	Hold	48	–	–	0.02%	145
2017 Q1	$82K	Hold	48	–	–	0.03%	150
2016 Q4	$34K	Hold	48	–	–	0.01%	154
2016 Q3	$47K	Hold	48	–	–	0.02%	155
2016 Q2	$56K	Hold	48	–	–	0.02%	136
2016 Q1	$48.7K	Buy	+48	New	+$47.2K	0.02%	160

Other funds holding MDVL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bristlecone Advisors's MDVL Position: Q3 2017 in Review

Bristlecone Advisors sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2017, closing a stake of 48 shares — an estimated $52K sold.

Bristlecone Advisors first reported a position in MDVL in Q1 2016 and held it in 6 quarters. The position peaked at $82K in Q1 2017. 7 funds tracked by Wall St. Rank hold MDVL as of Q3 2017.

Bristlecone Advisors reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Bristlecone Advisors sold 48 MedAvail Holdings, Inc. Common Stock shares in Q3 2017, an estimated $52K.
Bristlecone Advisors first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2016 and held it in 6 quarters.
Bristlecone Advisors's MedAvail Holdings, Inc. Common Stock position peaked at $82K in Q1 2017.
7 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2017.

Based on Bristlecone Advisors's 13F filing for Q3 2017, filed 20 Oct 2017.